SEGMENT INFORMATION (Tables)

6 Months Ended

Jan. 31, 2014

The following table presents sales and segment profit from continuing operations by business segment reconciled to earnings from continuing operations before income taxes for the three and six months ended January 31, 2014 and January 31, 2013.



	Three Months Ended				Six Months Ended
	Jan 31, 2014		Jan 31, 2013		Jan 31, 2014		Jan 31, 2013
SALES:
Life Sciences	$	353,230	$	329,182	$	672,176	$	629,133
Industrial	323,739		333,273		634,572		660,922
Total	$	676,969	$	662,455	$	1,306,748	$	1,290,055
SEGMENT PROFIT:
Life Sciences	$	90,856	$	82,477	$	163,901	$	152,319
Industrial	46,891		48,104		97,373		100,870
Total segment profit	137,747		130,581		261,274		253,189
Corporate Services Group	14,766		18,026		30,730		32,091
ROTC	9,170		4,399		18,368		8,673
Interest expense, net	5,195		6,017		11,172		5,449
Earnings from continuing operations before income taxes	$	108,616	$	102,139	$	201,004	$	206,976

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details